From CNBC: 2025-01-10 07:08:35

Walgreens reported fiscal first-quarter earnings and revenue that surpassed expectations, including earnings per share of 51 cents adjusted versus 37 cents expected and revenue of $39.46 billion versus $37.36 billion expected. Despite this, the company maintained its fiscal 2025 adjusted earnings guidance and saw shares climb over 5% in premarket trading.

During the first quarter, Walgreens experienced growth across its three business segments. The U.S. retail pharmacy division generated $30.87 billion in sales, with pharmacy sales rising 10.4% and comparable pharmacy sales increasing 12.7%. The U.S. health-care unit saw sales jump to $2.17 billion, reflecting growth in VillageMD and Shields Health Solutions.

The company reported a net loss of $265 million for the fiscal first quarter, driven by higher operating losses due to its plan to close underperforming stores. Walgreens plans to close 1,200 stores over the next three years. Despite challenges in the retail sector, the company remains focused on its turnaround efforts and sustainable operating model.



Read more at CNBC:: Walgreens (WBA) earnings Q1 2025